Avista Pharma Solutions, Inc. announced that Eric Evans has been named its Chief Financial Officer effective August 28, 2017. In this role, Mr. Evans will oversee the company’s finance, purchasing, and information technology operations and brings significant experience in leading private equity backed high-growth organizations.
With more than 30 years of industry experience, Mr. Evans has held leadership roles in high-growth companies across the pharmaceutical and contract service sectors. Prior to joining Avista Pharma, Mr. Evans was CFO of Mayne Pharma (USA), Inc., a $420 million pharmaceutical company.
He previously served as CFO of two other CDMOs: AAIPharma Services and Patheon Inc. He also held positions in the pharmaceutical industry as VP and Controller for Novartis Pharmaceuticals Corporation and VP and Controller of Sandoz Inc. Mr. Evans’ career includes leadership roles in a wide range of acquisitions and divestitures, business integrations, financings and ERP implementations.
“Eric has a proven track record of providing leadership in financial and operational strategies in growth organizations,” said Patrick Walsh, CEO of Avista Pharma Solutions, Inc. “His experience will ensure continued success for the company and our clients, and I am delighted to be working with him again.”
Mr. Evans received an MBA from the Weatherhead School of Management at Case Western Reserve University in Cleveland, Ohio. He also earned a master’s degree from the University of Western Ontario in London, Canada and a bachelor’s degree from Queen’s University in Kingston, Canada.
(Source: Avista Pharma Solutions, Inc.)
